Prescrire

In Prescrire’s Spotlight

Botulinum toxin type A for migraine:  FEATURED REVIEWGiven its uncertain efficacy, at best only modest, botulinum toxin type A is simply too risky a treatment for migraine. It is better to focus on fine tuning of standard prophylaxis. Full review (4 pages) available for download by subscribers. 1 December 2011

In the December issue of Prescrire International: Bleomycin in malignant pleural effusion FREE DOWNLOADSome cancer patients develop malignant pleural effusion that persists or recurs despite cytotoxic chemotherapy and drainage. For pleurodesis, it is better to choose talc rather than bleomycin, as it is safer and no less effective. Full text available for free download. 1 December 2011

To prevent repeats of the Mediator° (benfluorex) disaster: attitudes need to change Healthcare professionals and patients, as well as drug experts and health authorities, must learn to balance medicines’ harms against their benefits. 1 December 2011

Small gifts: proved to have an influence, albeit often unconscious Knowing that attitudes can be influenced by gifts – even small ones – and exposure to promotional items (posters, pens, etc.) helps to avoid being manipulated. 1 December 2011

Pharmaceutical companies and patient groups: the influence of funding Patients rely on patient groups to make their views heard, to participate in discussions and to defend their interests — not those of firms. 1 December 2011

Prescrire’s “Non merci…” Charter = no conflicts of interest In order to deliver the best possible care, healthcare professionals need to base their work and their decisions on reliable and independent information. 1 December 2011

Gingival hyperplasia can be drug-related Some drugs can cause gingival hyperplasia. Reducing the dose, halting treatment and good oral and dental hygiene are generally sufficient to reduce or stop the lesions. 1 December 2011

Related articles

• Could Botox Cure Your Headaches? (everydayhealth.com)
• Medications for Neck Pain Relief (everydayhealth.com)
• December 4, 2011 (tanyatgurl.wordpress.com)
• Global Botulinum Toxin Market to Reach US$3.8 Billion by 2017, According to a New Report by Global Industry Analysts Inc. (prweb.com)
• Migraine Surgery Offers Good Long-Term Outcomes (prweb.com)
• December 04, 2011 (isgl2a.wordpress.com)
• Sunday, December 4, 2011 (ttiptonmn.wordpress.com)
• Status Reports for December 4th, 2011 (reviewboardstudents.wordpress.com)
• XEOMIN (incobotulinumtoxinA) Data To Be Presented At The 72nd Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation (medicalnewstoday.com)
• Minimally Invasive Procedures (new-lift.com)

http://feeds.feedburner.com/MedicinaGeneralYFamiliar